Safety of Trypan Blue on Endothelium of Diabetic Retinopathy Patients

Cataract Diabetic Clinical Trial

Official title:
Safety of Trypan Blue Capsule Staining to Corneal Endothelium in Patients With Diabetic Retinopathy

Status Completed

Clinical Trial Summary

This study examines the use of Trypan Blue staining of the corneal endothelium in patients undergoing phacoemulsification. It is a single-center prospective, randomized individual cohort study. One eye in each patient with diabetic retinopathy will undergo phacoemulsification without Trypan Blue capsule staining (control eye) while the other eye will undergo phacoemulsification with Trypan Blue capsule staining (study eye). Both eyes will undergo intraocular lens implantation. Preoperative and four-week postoperative quantitative and qualitative morphometric endothelial cell analyses of the cornea will be performed using noncontact specular microscopy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03755752
Study type	Interventional
Source	Assiut University
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2018
Completion date	August 31, 2018

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04977427` - Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes	Phase 4
Recruiting	`NCT05386160` - Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy	Phase 4
Not yet recruiting	`NCT04668703` - Prophylactic Effect of Conbercept Intravitreal Injection at the Conclusion of Cataract Surgery for Diabetic Macular Edema	N/A